Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-12 · accession 0001507496-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-18 | 2025-02-12 | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | A - Grant | $0.00 | +13.1K | 41.5K | +46% | $0 |
| 2025-02-18 | 2025-02-14 | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $58.92 | -582 | 46.1K | -1% | -$34.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | A | A | 5,222 | $0.00 | 46,674 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-12 | A | A | 7,834 | $0.00 | 41,452 | D | — | — | (F2) Includes 449 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c). |
| 3 | Common | Common Stock | 2025-02-14 | F | D | 582 | $58.92 | 46,092 | D | — | — |